Brentview Investment Management’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.7M Sell
38,507
-5,403
-12% -$1.64M 6.6% 1
2026
Q1
$9.38M Buy
43,910
+1,637
+4% +$366K 4.06% 4
2025
Q4
$7.24M Buy
42,273
+66
+0.2% +$10.3K 3.27% 5
2025
Q3
$5.65M Sell
42,207
-6,236
-13% -$660K 2.58% 12
2025
Q2
$4.72M Sell
48,443
-859
-2% -$68.1K 2.38% 17
2025
Q1
$3.58M Buy
49,302
+2,067
+4% +$163K 1.91% 29
2024
Q4
$3.41M Buy
+47,235
New +$3.58M 1.94% 25

Other funds holding LRCX

Brentview Investment Management's LRCX Position: Q2 2026 in Review

Brentview Investment Management reduced its Lam Research (LRCX) stake by 12% in Q2 2026, selling an estimated $1.64M and leaving 38,507 shares worth $16.7M. The position accounts for 6.6% of the portfolio, ranked #1.

Brentview Investment Management first reported a position in LRCX in Q4 2024 and has held it in 7 quarters since. 1,427 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Brentview Investment Management held 38,507 shares of Lam Research worth $16.7M as of Q2 2026.
  • Brentview Investment Management sold 5,403 Lam Research shares in Q2 2026, an estimated $1.64M.
  • Lam Research made up 6.6% of Brentview Investment Management's portfolio in Q2 2026, its #1 holding.
  • Brentview Investment Management first reported a position in Lam Research in Q4 2024 and has held it in 7 quarters since.
  • 1,427 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Brentview Investment Management's 13F filing for Q2 2026, filed 30 Jul 2026.